Abstract: The change in augmentation index following salbutamol inhalation has been applied to evaluate endothelial function. We examined the contribution of salbutamol-induced increase in heart rate to the observed decrease in augmentation index. Haemodynamics were recorded using whole-body impedance cardiography and continuous pulse wave analysis from tonometric radial blood pressure. All subjects (n = 335, mean age 46, body mass index 26, 48% men) were without medications with cardiovascular influences. The effects of salbutamol inhalation (0.4 mg) versus the endothelium-independent agent nitroglycerin resoriblet (0.25 mg) were examined during passive head-up tilt, as the haemodynamic influences of these compounds depend on body position. Salbutamol decreased augmentation index by~3-4% units in supine and upright positions. Although salbutamol moderately increased cardiac index (+4.5%) and decreased systemic vascular resistance (À8.5%), the significant haemodynamic explanatory factors for decreased augmentation index in multivariate analysis were increased supine heart rate, and increased upright heart rate and decreased ejection duration (p < 0.001 for all, r 2 = 0.36-0.37). Sublingual nitroglycerin decreased supine and upright augmentation index by~15% units and~23% units, respectively. The haemodynamic explanatory factors for these changes in multivariate analysis were increased heart rate, reduced ejection duration and reduced systemic vascular resistance (p ≤ 0.021 for all, r 2 = 0.22-0.34). In conclusion, the lowering influence of salbutamol on augmentation index may be largely explained by increased heart rate, suggesting that this effect may not predominantly reflect endothelial function.
The b 2 -adrenoceptor agonist salbutamol can induce endothelium-dependent vasodilation both in vitro and in vivo [1] [2] [3] [4] [5] . In 2002, two reports suggested that the change in augmentation index (AIx) after salbutamol inhalation could provide a noninvasive method for evaluating endothelial function in vivo [6, 7] . In previous papers, the effect of salbutamol has been compared with that of sublingual nitroglycerin, which induces an endothelium-independent change in haemodynamics [7] [8] [9] .
Salbutamol has a documented positive chronotropic effect [4, 6, 10, 11] . A rise in heart rate shortens the cardiac cycle and time to peak systolic pressure, but does not directly affect the propagation of the reflected pressure wave from the peripheral circulation [12] [13] [14] . Subsequently, during higher heart rate, the systole is shortened and the reflected pressure wave returns relatively later during the cardiac cycle, reducing the magnitude of AIx [7, 12, 13] . In our previous study, salbutamol inhalation in parallel increased heart rate and decreased AIx in 35 healthy volunteers [15] . Most of the studies that have examined the effect of salbutamol inhalation on AIx have not adjusted the results for the simultaneous changes in heart rate [16] [17] [18] [19] [20] [21] .
In addition to changes in endothelium-mediated control of arterial tone and heart rate, b 2 -adrenoceptor stimulation enhances cardiac conduction and has a positive inotropic effect [11, 22, 23] . These factors could also influence AIx. Two previous studies have evaluated cardiac output and vascular resistance with parallel monitoring of AIx after salbutamol inhalation [7, 15] . However, these studies examined the salbutamol-induced changes in AIx, cardiac function and peripheral vascular resistance in rather small groups of subjects (n = 12-35).
The impact of salbutamol inhalation on AIx could at least partially be mediated via the chronotropic properties of b 2 -adrenoceptor stimulation. To test this hypothesis, we compared the acute cardiovascular effects of inhaled salbutamol versus sublingual nitroglycerin in 335 subjects, who were all without medications with direct cardiovascular influences. As upright posture attenuates the haemodynamic effects of salbutamol but accentuates those of nitroglycerin [15] , we employed a passive head-up tilt to provoke changes in haemodynamics.
Methods
Study subjects. Voluntary subjects were recruited from occupational healthcare providers in the Pirkanmaa Hospital District, from Tampere University Hospital, University of Tampere, Varala Sports Institute, and one announcement was published in a local newspaper. The subjects who responded were recruited in the order that they contacted the research nurse. All subjects underwent physical examination and routine laboratory analyses. The lifestyle habits, family history and medical history were recorded. Normotensive subjects and patients with never-treated primary hypertension [24] were included, and subjects with other cardiovascular diseases were excluded [25] [26] [27] . Information about possible pregnancy was also a reason for exclusion. Altogether 335 subjects without antihypertensive medication or use of Author for correspondence: Antti J. Tikkakoski, Faculty of Medicine and Life Sciences, P.O. Box 100, FIN-33014 University of Tampere, Tampere, Finland (e-mail antti.tikkakoski@iki.fi).
b 2 -sympathomimetics were included in this study. Those with office blood pressure (BP) ≥140/90 mmHg had never been treated for hypertension. The study complied with the Declaration of Helsinki, was approved by the ethics committee of the Tampere University Hospital (Study code R06086M) and the Finnish Medicines Agency (Eudra-CT number 2006-002065-39) and was registered in a database (clinicaltrials.gov NCT01742702). Written informed consent was obtained from all participants in the study.
Laboratory analyses. Blood and urine samples were drawn after 12 hr of fasting. Plasma sodium, potassium, glucose, creatinine, triglyceride and total, high-density and low-density lipoprotein cholesterol concentrations were determined using Cobas Integra 700/ 800 or Cobas 6000, module c501 (F. Hoffmann-LaRoche Ltd, Basel, Switzerland), and blood cell count by ADVIA 120 or 2120 (Siemens Healthcare GmbH, Erlangen, Germany). Estimated glomerular filtration rate was calculated using the RULE formula, as the values were within the normal range [28] .
Pulse wave analysis. Radial BP and pulse waveform were continuously recorded by the use of an automated tonometric sensor (Colin BP-508T, Colin Medical Instruments Corp., San Antonio, Texas, USA) [15, 25, 26] . The left radial BP signal was calibrated every 2-4 min. by right-side brachial BP measurements. Aortic BP was derived (SpygmoCor PWMx, Atcor medical, Australia) using a validated generalized transfer function [29] . AIx (augmented pressure/ pulse pressure*100) was determined using the pulse wave analysis software from the calculated central pulse wave [29] .
Whole-body impedance cardiography (CircMon R , JR Medical Ltd., Tallinn, Estonia) was applied to record changes in body electrical impedance during cardiac cycles to determine beat-to-beat stroke volume, cardiac output and pulse wave velocity [27, 30, 31] . Heart rate was determined from a single channel electrocardiogram (ECG). Systemic vascular resistance (SVR) was calculated from the radial BP signal and cardiac output measured by the CircMon R device. SVR was calculated by subtracting normal central venous pressure (4 mmHg) from mean arterial pressure and dividing it by cardiac output. Cardiac output and SVR were related to body surface area (presented as cardiac index and SVRI, respectively). The stroke volume measured using CircMon R agrees well with values measured using three-dimensional ultrasound in the upright position [26] . The supine and upright cardiac output values measured with CircMon R agree well with the values measured using thermodilution [31, 32] . The pulse wave velocity values recorded using CircMon R show very good correlations with values measured using ultrasound and the tonometric SphygmoCor method [27, 30, 31] .
Experimental protocol. Haemodynamic measurements were performed in a quiet temperature-controlled laboratory [15, 25, 26, 33] . Caffeinecontaining products, smoking and a heavy meal for at least 4 hr, and alcohol for at least 24 hr prior to the investigation were to be avoided. The left arm with the tonometric sensor was abducted to 90°in an arm support that kept it at the level of the heart [15, 25, 26, 33] . The measurement comprised three 5-min. periods with continuous capture of data: 5-min. supine -5 min. of head-up tilt to 60°-5-min. supine. Then, sublingual nitroglycerin 0.25 mg (Nitro resoriblet; Orion Pharma, Espoo, Finland) was given and the protocol was repeated. After a break of ≥1 hr, the protocol was repeated using salbutamol 400 lg inhalation as the test drug (2*200 lg at 1-min. intervals, Ventoline R with Volumatic R spacer, GlaxoSmithKline, Uxbridge, Middlesex, UK). The supine and upright repeatability and reproducibility of the haemodynamic measurements is good [33] . Corresponding drug doses were previously applied to examine the effects on AIx [4, [6] [7] [8] , and plasma salbutamol concentration was shown to remain stable at 5-20 min. after 400 lg salbutamol inhalation. A period of 20 min. after sublingual nitroglycerin was reported to be sufficient for the haemodynamic changes to return to baseline [7] .
Statistics. Data were analysed using R software (www.R-project.org) and SPSS 17.0 (SPSS Inc., Chicago, IL, USA). Differences between non-medicated and medicated phases were examined using analysis of variance (ANOVA) for repeated measurements. Linear regression was employed to examine the changes in haemodynamics in response to salbutamol or nitroglycerin. The variables showing a statistically significant change in univariate analyses after salbutamol or nitroglycerin administration were included in the regression analyses: heart rate, stroke index, pulse wave velocity, ejection duration and SVRI. For the regression analyses, the average values recorded during the last 2 min. at rest before test-drug administrations (i.e. averages of 120 cardiac cycles) served as the reference values, and for the drug responses the mean values of the last 3 supine minutes preceding the head-up tilt, the last 3 min. during the head-up tilt, and the last 3 min. in supine position after the head-up tilt were calculated, as during these periods, the signal was most stable [25] . Additional multivariate analyses were performed so that age, sex, body mass index and BP status were included as covariates. As the level of BP is significantly lower during the haemodynamic measurements than in the office, the cut-point for low and high BP was 135/85 mmHg [25] . The results concerning AIx and heart rate were depicted both as absolute values and as changes from the average values of the last 2 min. at rest before the drug administrations. p-values <0.05 were considered statistically significant. In some studies, AIx has been adjusted to heart rate 75 beats/min using previous gender-and age-based reference values [7, 13] . However, this method does not take into account differences in the interactions between heart rate and AIx in different populations [34] . Therefore, we used heart rate as an independent predictor in the statistical analyses rather than using the AIx values that were adjusted to heart rate 75 beats/min with the SphygmoCor software.
Results

Study population.
The mean age was 46 years and body mass index 26, and the proportion of male subjects 48% (table 1). The age range was 19-72 years in male subjects and 21-72 years in female subjects. The prevalence of present and previous smokers was 13% and 30%, respectively. Average alcohol use was moderate 2.7 standard drinks/week. None of the subjects used antihypertensive medicines. Based on office BP, the proportion of never-medicated hypertensive subjects was 52% [24] . Average measures of electrolytes, glucose metabolism and renal function were within the normal range (table 1) .
Salbutamol-induced changes in haemodynamics.
Salbutamol inhalation did not influence systolic BP in the subjects ( fig. 1A ), but a small initial lowering of diastolic BP before the head-up tilt was observed ( fig. 1C ). When the response was compared with the preceding 15-min. recording, salbutamol moderately decreased AIx after the head-up tilt ( fig. 2A) The variables that could explain the reduction in AIx, that is heart rate, SVRI, stroke index and ejection duration, were explored using multivariate regression analysis (table 2) . In supine position, the decrease in AIx correlated with the increase in heart rate (p < 0.001) (table 2). During head-up tilt, the decrease in AIx after salbutamol was associated with the rise in heart rate and reduction in ejection duration (table 3A) . When the AIx values from the 2 min. preceding drug administration served as reference, the salbutamolinduced changes in AIx during head-up tilt were corresponding in magnitude to the changes in supine position ( fig. 2C , tables 2 and 3). When age, sex, body mass index and BP status (<135/85 or ≥135/85 mmHg during haemodynamic recordings [25] ) were included in the multivariate analyses, age was the only factor in addition to changes in heart rate and ejection duration that had a significant influence on the change in AIx in response to salbutamol (Tables S1 and S2) . 4D ). Nitroglycerin decreased ejection duration during and after the head-up tilt ( fig. 5D ). The nitroglycerin-induced decrease in AIx correlated with the parallel increase in heart rate, but the correlation coefficient was lower than that after salbutamol (r = 0.333-0.377, p < 0.001) ( fig. 6B,D) .
In multivariate regression analysis, the nitroglycerin-induced decrease in AIx was associated with increased heart rate and reduced ejection duration before the head-up tilt, and with reduced ejection duration and decreased SVRI after the headup tilt (table 4). In the upright position, the nitroglycerininduced decrease in AIx correlated with increased heart rate, decreased systemic vascular resistance and reduced ejection duration (table 3B) . The nitroglycerin-induced changes in haemodynamic variables were larger in the upright than in the supine position (figs. 1B, 2B, 3B, 4B,D, tables 3 and 4).
When age, sex, body mass index and BP status were included in the multivariate analyses, the nitroglycerin-induced supine decrease in AIx was associated with age, female sex and body mass index in addition to changes in heart rate and ejection duration before the head-up tilt; and with age and body mass index in addition to changes in heart rate, ejection duration, pulse wave velocity and SVRI after the head-up tilt (Table S3 ). The nitroglycerin-induced upright decrease in AIx correlated with age in addition to changes in heart rate, SVRI and ejection duration (Table S2 ).
Discussion
The effects of wave reflections on the central pressure wave shape are influenced by systolic ejection time, heart rate, arterial diameter, wall elasticity, wall thickness, arterial branching and resistance to flow in small arteries [35] . The present study compared the changes in AIx induced by salbutamol inhalation versus sublingual nitroglycerin in 335 subjects not using medications with direct cardiovascular actions. Several variables with potential influences on AIx were simultaneously recorded, and the effect of salbutamol on AIx appeared to be mainly correlated with parallel changes in heart rate. During head-up tilt, there was an additional relation between the changes in AIx and ejection duration. The nitroglycerininduced change in AIx was associated with heart rate, systemic vascular resistance and ejection duration. These findings suggest that the salbutamol-induced changes in AIx may not predominantly reflect endothelium-dependent vasodilatation in the vasculature. Of note, age had a significant influence on the AIx response to salbutamol both supine and upright.
An increase in heart rate shortens the duration of systole, so that the reflected wave arrives when pressure is already decreasing, resulting in a lower AIx [13] . In contrast, b-adrenoceptor blockers increase AIx due to the reduction in heart rate [36, 37] . The positive chronotropic effect of salbutamol and other b 2 -mimetics is well known [4, 6, 10, 11, 15, 23, [38] [39] [40] [41] . In the previous studies, the effects of b 2 -adrenoceptor stimulation have been compared with baseline AIx values [6,7,13,39- 41]. In the present study, the salbutamol-induced decreases in AIx (when compared with values from the 2 min. preceding the inhalations) and SVRI, and an increase in cardiac index, were immediately detected during the first 2 min. after the inhalations. In contrast, the lowering influence of nitroglycerin on AIx started 2 min., and on SVRI started 3 min., after drug administration. The rapid changes in haemodynamics following salbutamol inhalation seemed to be secondary events to the positive chronotropic effect of b 2 -adrenoceptor stimulation, as inhaled salbutamol has a rapid access from the alveoli to the heart via the pulmonary veins. The results of the regression analyses support the view that increased cardiac output and decreased SVRI were secondary events to the increased heart rate. As previously, sublingual nitroglycerin increased heart rate and cardiac output [4, 15] . Increased heart rate and decreased ejection duration explained the nitroglycerin-induced reduction in AIx before the head-up tilt, while the lowering impact of reduced SVRI on AIx was significant during and after the head-up tilt. Autonomic and hormonal regulation can quickly change haemodynamics [35, 42] . In most of the former studies, AIx and heart rate were recorded by capturing 10-20 consecutive pulse waves [6, 8, 43] . The present 15-min. recordings were probably less prone to deviations than shorter measurements. Also, being aware of the moment of measurement very likely influences the outcome of the recordings. In most studies, BP and AIx were recorded sequentially [6, 7, 13, [39] [40] [41] , and the gap between BP measurement and capture of pulse wave could be several minutes. We applied simultaneous recordings of BP, heart rate and radial pulse wave [33] .
The stimulation of b 2 -adrenoceptors has been found to induce endothelium-dependent vasorelaxation in many studies [1] [2] [3] [4] [5] . For instance, intra-arterial infusion of salbutamol has been reported to induce endothelium-mediated vasodilatation in the forearm [3] . Experiments in vitro have shown that salbutamol-induced vasodilatation is reduced by the inhibition of nitric oxide (NO) synthesis and abolished by removal of the endothelium [2, 3] . In 10 healthy human subjects, 26% decrease in the inflection point of digital volume pulse, a measure of wave reflection, and parallel 18% increase in heart rate, was reported after 400 lg salbutamol inhalation [4] . In the presence of the NO-synthase inhibitor N G -monomethyl-Larginine (L-NMMA), the decrease in the inflection point following salbutamol was reduced to 5% and the increase in heart rate to 7% [4] . Thus, the response to salbutamol was modulated by NO release, but regulation of heart rate also differed in the absence and presence of L-NMMA. After the above findings, the salbutamol-induced reduction in AIx has been applied as a non-invasive method to evaluate endothelial function in vivo, with the hypothesis that the changes are mediated via stimulation of endothelial b 2 -adrenoceptors [6] [7] [8] . However, experiments using NO-synthase inhibitor do not prove that the observed changes in AIx are due to alterations in NO release, as acute increases in BP activate baroreflexes, and reduce heart rate and cardiac output [44] . Indeed, L-NMMA infusion elevates arterial pressure and reduces heart rate in humans [6, 7] .
The discrepancies between the present and previous studies on the salbutamol-induced changes in AIx and heart rate call for elaboration, as the applied drug doses were quite corresponding [6] [7] [8] . In three studies, BP and AIx were recorded sequentially, not simultaneously. In two studies comprising 11 and 40 subjects, the changes in AIx after salbutamol inhalation did not correlate with changes in heart rate [6, 7] , while increased heart rate was an explanatory factor for decreased AIx in 54 subjects [13] . In two studies comprising 220 and 40 subjects, neither salbutamol nor nitroglycerin influenced heart rate [8, 9] . In one study, the increases in heart rate in 11-12 young male subjects were higher after salbutamol than after nitroglycerin, and in that study, salbutamol was administered 25 min. after nitroglycerin [7] . We previously found that the haemodynamic effects of sublingual 0.25 mg nitroglycerin exceeded 20 min. of time [45] . In one study, the salbutamol response was defined as the maximum observed change in AIx in recordings performed at 3-5-min. intervals during 20 min. after drug administration [8] . Here, we included all AIx values recorded during the 15-min. protocol in the analyses. Of note, if endothelial function is defined as the ratio of the change in AIx after salbutamol relative to that after nitroglycerin [8] , the present results could be interpreted to show that endothelial function depends significantly on posture.
Lind and coworkers examined the effect of terbutaline (0.25 mg subcutaneously) on arterial wave reflections [39] [40] [41] and focused on radial reflectance index, that is magnitude of first reflected wave in diastole to first pressure peak in systole, a variable that showed only minor differences from AIx [40] . Terbutaline decreased radial reflectance index (from 46 to 29%) and increased HR by 15-22 beats/min, in 20-to 29- year-old healthy volunteers [39] . The reduction in reflectance index was related to the parallel increase in HR (r~À0.5). The terbutaline-induced decrease in reflectance index was attenuated by L-NMMA, while the parallel increase in heart rate was decreased from 22 to 11 beats/min [39] , indicating a contribution of lower increase in heart rate to the response. In 1016 elderly subjects, acetylcholine-induced vasodilatation in the forearm was, while terbutaline-induced reduction in radial reflectance index was not [40] , associated with the Framingham coronary heart disease risk score [46] . The acetylcholineinduced vasodilation, but not the change in radial reflectance index in response to terbutaline, was associated with the 5-year risk of a composite end-point of death, myocardial infarction or stroke independently of major cardiovascular risk factors [41] . Taken together, the findings by Lind and coworkers also question the view that changes in wave reflections following b 2 -adrenoceptor agonist administration would be independent of changes in heart rate and predominantly reflect endothelial function in vivo [39] [40] [41] . Although the present findings suggest that the reduction in AIx following salbutamol inhalation is predominantly related to the parallel increase in heart rate, these results do not exclude the possibility that part of the observed change is mediated by the stimulation of the endothelial cells. As a limitation our study was not placebo-controlled, but we previously performed a placebo-controlled study that showed similar effects of salbutamol on heart rate and AIx as the present investigation [15] . The previous study was not suited for multivariate analyses due to the low number of subjects (35 healthy volunteers) [15] . We applied non-invasive recordings to evaluate cardiac output, and this requires mathematical equations and simplification of physiology [31] , but invasive haemodynamic measurements are not justified without a clinical indication. The present methods have been validated against invasive methods, three-dimensional ultrasound, and tonometric measurements of pulse wave velocity [26, 27, 29, 31] . Nevertheless, systemic vascular resistance was indirectly determined from the tonometric BP recordings and cardiac output measurements using wholebody impedance cardiography, and the results must be interpreted with caution. However, the haemodynamic responses induced by nitroglycerin were logic, implying that the results concerning the effects of salbutamol were also reliable. Finally, we did not apply established methods like flowmediated vasodilatation of brachial artery or acetylcholineinduced vasodilatation in the forearm to evaluate the endothelium-mediated control of arterial tone [40] . Comparison of the salbutamol-induced change in AIx with such variables reflecting endothelium-dependent control of vascular tone in a large enough group of subjects would offer more insight about the relations between wave reflections and endothelial function. Fig. 6 . Correlation between changes in heart rate and augmentation index. Scatter plot of change in heart rate versus change in augmentation index induced by salbutamol (A) or nitroglycerin (B) in supine position before the head-up tilt, and scatter plot of change in heart rate versus change in augmentation index induced by salbutamol (C) or nitroglycerin (D) in supine position after the head-up tilt.
In conclusion, both salbutamol and nitroglycerin reduced AIx and increased heart rate. However, the salbutamol-induced effects on both of these variables were significantly correlated, suggesting that the observed influences on AIx may not predominantly reflect endothelium-dependent vasodilation in vivo. Altogether, the parallel alterations in heart rate should be No haemodynamically independent change in augmentation index was observed (p = 0.551 for constant) in analyses adjusted for changes in heart rate, SVRI, stroke index and ejection duration. If heart rate in parallel would increase by 10 beats/min., then augmentation index would decrease by 5.4% units, and the total decrease would also be 5.4% units. CI, confidence interval; SVRI, systemic vascular resistance index. Only such haemodynamic variables were included in the analyses that significantly changed after either salbutamol or nitroglycerin administration. Table 3 . Multivariate analysis of salbutamol-and nitroglycerin-induced changes in upright augmentation index in 335 subjects. First, a passive head-up tilt (5-min. supine, 5-min. upright, 5-min. supine) was performed, then 0.25 mg of nitroglycerin was given sublingually, and the 15-min. tilt protocol was repeated. After a break of at least 1 hr, passive head-up tilt was again performed and then 400 lg of salbutamol was inhaled, and the 15-min. tilt protocol was repeated.
A. Salbutamol effect during upright phase (5-10 min. of recording) Change in augmentation index (% units) carefully taken into account when examining the changes in AIx in response to b 2 -adrenoceptor agonists and other chronotropic agents. Table 4 . Multivariate analysis of nitroglycerin-induced changes in supine augmentation index in 335 subjects. First, a passive head-up tilt (5-min. supine, 5-min. upright, 5-min. supine) was performed, then 0.25 mg of nitroglycerin was given sublingually, and the 15-min. tilt protocol was repeated.
A. Supine phase before head-up tilt (0-5 min. of recording)
Change in augmentation index (% units) Example of interpretation (table A, supine phase before head-up tilt): Nitroglycerin reduced augmentation index by 9.45% units (p < 0.001) in analyses adjusted for changes in heart rate, SVRI, stroke index and ejection duration. If heart rate in parallel would increase by 10 beats/min., then augmentation index would decrease by additional 2.6% units, and the total decrease would be 12.05% units. CI, confidence interval; SVRI, systemic vascular resistance index. Only such haemodynamic variables were included in the analyses that significantly changed after either salbutamol or nitroglycerin administration.
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